PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1465582
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1465582
Empty Capsules Market Size - By Type (Gelatin, Vegetarian Capsules), Source (Porcine Gelatin, Bovine Derived Gelatin, Bone Meal, Starch Materials & Pullulan), Functionality, Capsule Size, Application, End-user & Global Forecast, 2024 - 2032
Global Empty Capsules Market size will exhibit a 7.7% CAGR between 2024 and 2032, owing to ongoing advancements in capsule manufacturing technologies in line with the increasing preference for both gelatin and non-gelatin capsules. These advancements improve capsule quality, stability, and compatibility with various formulations. Gelatin-based capsules remain popular in the pharmaceutical and nutraceutical sectors, while non-gelatin options like HPMC and pullulan cater to vegetarian and vegan preferences. This dual trend of technological innovation and diverse capsule preferences will propel the empty capsules industry forward.
For instance, in February 2023, Vivion, Inc., a brand of Operio Group and a global ingredient solutions provider, launched a new range of HPMC, empty gelatin, and pullulan capsules.
The empty capsules industry is fragmented based on type, source, functionality, capsule size, application, end-user, and region.
The nutraceuticals industry segment will establish a notable market foothold by 2032, attributed to the increasing demand for dietary supplements and functional foods worldwide. Empty capsules provide a convenient and customizable delivery method for nutraceutical products, appealing to consumers seeking health and wellness solutions. With a focus on natural ingredients and wellness trends, the nutraceuticals industry will drive demand for empty capsules.
The empty capsules market share from the bovine-derived gelatin segment will record a significant uptick from 2024 to 2032 due to its widespread use in pharmaceuticals, nutraceuticals, and dietary supplements. Bovine gelatin capsules offer excellent stability and compatibility with a variety of formulations, making them a preferred choice for manufacturers. With a rising demand for gelatin-based capsules in the pharmaceutical industry and the increasing popularity of nutraceuticals, the bovine-derived gelatin segment will maintain its dominance in the empty capsules market.
Asia Pacific empty capsules market will secure a noteworthy CAGR between 2024 and 2032, driven by expanding pharmaceutical and nutraceutical industries, especially in countries like China and India. Rising healthcare expenditures and a growing aging population also contribute to the demand for empty capsules. With increasing investments in research and development, Asia Pacific will emerge as a key contributor to the market's expansion, offering a wide range of applications in drug delivery and dietary supplements.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Base estimates & calculations
- 1.3 Data collection
- 1.4 Forecast parameters
- 1.5 Data validation
- 1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
- 1.6.2.1 Paid sources
- 1.6.2.2 Public sources
Chapter 2 Executive Summary
- 2.1 Industry 360 degree synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Technological advancements in empty capsules
- 3.2.1.2 Growing prevalence of chronic ailments such as cardiovascular diseases worldwide
- 3.2.1.3 Increasing intake of dietary supplements and vitamins
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Fluctuating raw material prices
- 3.2.2.2 Cultural practices and dietary restrictions
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Porter's analysis
- 3.5.1 Supplier power
- 3.5.2 Buyer power
- 3.5.3 Threat of new entrants
- 3.5.4 Threat of substitutes
- 3.5.5 Industry rivalry
- 3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Competitive positioning matrix
- 4.4 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Million)
- 5.1 Key trends
- 5.2 Gelatin based capsules
- 5.2.1 Hard capsules
- 5.2.2 Soft capsules
- 5.3 Vegetarian capsules
Chapter 6 Market Estimates and Forecast, By Source, 2018 - 2032 ($ Million)
- 6.1 Key trends
- 6.2 Porcine gelatin
- 6.3 Bovine derived gelatin
- 6.4 Bone meal
- 6.5 Hydroxy propyl methyl cellulose (HPMC)
- 6.6 Starch materials & pullulan
Chapter 7 Market Estimates and Forecast, By Functionality, 2018 - 2032 ($ Million)
- 7.1 Key trends
- 7.2 Immediate release
- 7.3 Sustained release
- 7.4 Delayed release
Chapter 8 Market Estimates and Forecast, By Capsule Type, 2018 - 2032 ($ Million)
- 8.1 Key trends
- 8.2 Size "000
- 8.3 Size "00"
- 8.4 Size "0"
- 8.5 Size "1"
- 8.6 Size "2"
- 8.7 Size "3"
- 8.8 Size "4"
- 8.9 Size "5"
Chapter 9 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Million)
- 9.1 Key trends
- 9.2 Antibiotic and antibacterial drugs
- 9.3 Vitamins and dietary supplements
- 9.4 Antacid and antiflatulent preparations
- 9.5 Cardiovascular therapy drugs
- 9.6 Other therapeutic applications
Chapter 10 Market Estimates and Forecast, By End-User, 2018 - 2032 ($ Million)
- 10.1 Key trends
- 10.2 Pharmaceuticals industry
- 10.3 Nutraceuticals industry
- 10.4 Cosmetics industry
- 10.5 Research laboratories
Chapter 11 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Million)
- 11.1 Key trends, by region
- 11.2 North America
- 11.2.1 U.S.
- 11.2.2 Canada
- 11.3 Europe
- 11.3.1 Germany
- 11.3.2 UK
- 11.3.3 France
- 11.3.4 Italy
- 11.3.5 Spain
- 11.3.6 Rest of Europe
- 11.4 Asia Pacific
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 Australia
- 11.4.5 South Korea
- 11.4.6 Rest of Asia Pacific
- 11.5 Latin America
- 11.5.1 Brazil
- 11.5.2 Mexico
- 11.5.3 Rest of Latin America
- 11.6 Middle East and Africa
- 11.6.1 South Africa
- 11.6.2 Saudi Arabia
- 11.6.3 Rest of Middle East and Africa
Chapter 12 Company Profiles
- 12.1 ACG
- 12.2 Bright Pharma Caps Inc.
- 12.3 CapsCanada Corporation
- 12.4 Erawat Pharma Limited
- 12.5 HealthCaps India
- 12.6 Lonza Group
- 12.7 Medi-Caps Ltd.
- 12.8 Mitsubishi Chemical Holdings Corporation
- 12.9 Nectar Lifesciences Ltd.
- 12.10 Qingdao Yiqing Biotechnology Co., Ltd.
- 12.11 Seoheung Co., Ltd.
